HCA Healthcare (HCA) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $7.59
- EPS estimate
- $7.56
- EPS surprise
- +0.37%
- Revenue surprise
- +2.40%
- Revenue
- $20.2B
- Revenue estimate
- $19.8B
- Reported
- Jul 24, 2026
HCA reported Q2 2026 results on July 24, 2026. Earnings per share were $7.59, just ahead of the $7.56 estimate by 0.37%. Revenue was $20.2 billion, 2.40% above the $19.8 billion consensus. Compared with Q2 2025, EPS rose about 11% from $6.84 and revenue rose about 9% from $18.6 billion.
The longer record shows steady growth. Annual EPS rose from $16.90 in 2022 to $19.03 in 2023, $21.98 in 2024 and $28.26 in 2025. The first half of 2026 adds up to $14.74, about 11% more than the $13.29 of a year earlier. Annual revenue rose every year, from $60.2 billion in 2022 to $75.6 billion in 2025. Q2 2026 set the quarterly revenue high in the table. The highest quarterly EPS here was $8.01, in Q4 2025. Over the last 20 quarters, HCA beat EPS estimates 15 times. The last two beats were narrow, at 0.36% and 0.37%.
HCA reported Q3 between October 21 and October 25 in each of the past five years. That points to late October 2026 for the next report. It will show whether the double-digit EPS growth of the first half carries into the third quarter.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 24, 2026 | $7.56 | $7.59 | +0.37% | $20.2B | SEC |
| Q1 2026 | Apr 24, 2026 | $7.12 | $7.15 | +0.36% | $19.1B | SEC |
| Q4 2025 | Jan 27, 2026 | $7.46 | $8.01 | +7.37% | $19.5B | SEC |
| Q3 2025 | Oct 24, 2025 | $5.79 | $6.96 | +20.17% | $19.2B | SEC |
| Q2 2025 | Jul 25, 2025 | $6.29 | $6.84 | +8.68% | $18.6B | SEC |
| Q1 2025 | Apr 25, 2025 | $5.75 | $6.45 | +12.19% | $18.3B | SEC |
| Q4 2024 | Jan 24, 2025 | $6.13 | $6.22 | +1.46% | $18.3B | SEC |
| Q3 2024 | Oct 25, 2024 | $4.96 | $4.90 | −1.16% | $17.5B | SEC |
| Q2 2024 | Jul 23, 2024 | $4.93 | $5.50 | +11.49% | $17.5B | SEC |
| Q1 2024 | Apr 26, 2024 | $5.06 | $5.36 | +6.01% | $17.3B | SEC |
| Q4 2023 | Jan 30, 2024 | $5.05 | $5.90 | +16.89% | $17.3B | SEC |
| Q3 2023 | Oct 24, 2023 | $3.98 | $3.91 | −1.64% | $16.2B | SEC |
| Q2 2023 | Jul 27, 2023 | $4.25 | $4.29 | +1.02% | $15.9B | SEC |
| Q1 2023 | Apr 21, 2023 | $3.91 | $4.93 | +26.02% | $15.6B | SEC |
| Q4 2022 | Jan 27, 2023 | $4.79 | $4.64 | −3.14% | $15.5B | SEC |
| Q3 2022 | Oct 21, 2022 | $3.88 | $3.93 | +1.28% | $15.0B | — |
| Q2 2022 | Jul 22, 2022 | $3.70 | $4.21 | +13.80% | $14.8B | — |
| Q1 2022 | Apr 22, 2022 | $4.26 | $4.12 | −3.34% | $14.9B | — |
| Q4 2021 | Jan 27, 2022 | $4.52 | $4.42 | −2.12% | $15.1B | — |
| Q3 2021 | Oct 22, 2021 | $4.06 | $4.57 | +12.51% | $15.3B | — |
Quarterly revenue
Frequently asked questions
When did HCA Healthcare (HCA) last report earnings?
HCA Healthcare last reported on Jul 24, 2026, covering fiscal Q2 2026.
Did HCA beat earnings estimates?
Yes. HCA Healthcare reported EPS of $7.59 for Q2 2026 against a $7.56 estimate — a 0.37% beat.
How much revenue did HCA report last quarter?
HCA Healthcare reported $20.2B in revenue for Q2 2026, against a consensus estimate of $19.8B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.